The First International Summit on Interventional Pharmacoeconomics
ZOOM Meeting
June 29 – July 1, 2020 8 am – 1 pm ET daily
Video recordings of the sessions can be viewed at the ASCO Post
ABOUT
The high cost of medications is a major challenge for patients and healthcare systems around the world. The emerging field of interventional pharmacoeconomics (see recent paper in JAMA Oncology) identifies opportunities for lower doses, shorter treatment durations, increased treatment intervals, and use of alternative agents. The aim is to use pharmacological and clinical knowledge to lower costs while maintaining equivalent health outcomes. This conference will bring together leaders in this field of research from the fields of pharmacology, health policy and economics, clinical medicine, clinical trials and health care management.
CONFERENCE LEADERSHIP

Daniel Goldstein
Davidoff Center, Rabin Medical Center, Israel

Mark Ratain
University of Chicago Medicine
WELCOME AND KEYNOTE SPEAKER

Welcome Address
Allen Lichter
Value in Cancer Care Consortium

Keynote Speaker
Clifford A Hudis
American Society of Clinical Oncology
SESSION TOPICS
PROOF OF CONCEPT
HIGH- VALUE OPPORTUNITIES
CLINICAL TRIAL DESIGN: STATISTICAL OPTIONS/CHALLENGES
BIOSIMILARS AND PATENT ISSUES
CREATING THE INFRASTRUCTURE FOR INTERVENTIONAL PHARMACOECONOMIC TRIALS
OPPORTUNITIES TO OPTIMIZE CANCER DRUG POLICIES
THE INTERVENTIONAL PHARMACOECONOMIC TOOLBOX
FOCUS ON OPTIMAL DOSING OF IBRUTINIB
Hosted by



SUMMIT MEETING REGISTRATION OPTIONS
3 days Full Price $500
3 days Discount Price (nonprofit and government employees, students) $50
